Cargando…
Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post-Mortem Brain of Schizophrenia, Parkinson’s and Alzheimer’s Disease Patients
Schizophrenia (SCZ) is a mental illness characterized by aberrant synaptic plasticity and connectivity. A large bulk of evidence suggests genetic and functional links between postsynaptic abnormalities and SCZ. Here, we performed quantitative PCR and Western blotting analysis in the dorsolateral pre...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835961/ https://www.ncbi.nlm.nih.gov/pubmed/35163460 http://dx.doi.org/10.3390/ijms23031539 |
_version_ | 1784649560746885120 |
---|---|
author | Di Maio, Anna De Rosa, Arianna Pelucchi, Silvia Garofalo, Martina Marciano, Benedetta Nuzzo, Tommaso Gardoni, Fabrizio Isidori, Andrea M. Di Luca, Monica Errico, Francesco De Bartolomeis, Andrea Marcello, Elena Usiello, Alessandro |
author_facet | Di Maio, Anna De Rosa, Arianna Pelucchi, Silvia Garofalo, Martina Marciano, Benedetta Nuzzo, Tommaso Gardoni, Fabrizio Isidori, Andrea M. Di Luca, Monica Errico, Francesco De Bartolomeis, Andrea Marcello, Elena Usiello, Alessandro |
author_sort | Di Maio, Anna |
collection | PubMed |
description | Schizophrenia (SCZ) is a mental illness characterized by aberrant synaptic plasticity and connectivity. A large bulk of evidence suggests genetic and functional links between postsynaptic abnormalities and SCZ. Here, we performed quantitative PCR and Western blotting analysis in the dorsolateral prefrontal cortex (DLPFC) and hippocampus of SCZ patients to investigate the mRNA and protein expression of three key spine shapers: the actin-binding protein cyclase-associated protein 2 (CAP2), the sheddase a disintegrin and metalloproteinase 10 (ADAM10), and the synapse-associated protein 97 (SAP97). Our analysis of the SCZ post-mortem brain indicated increased DLG1 mRNA in DLPFC and decreased CAP2 mRNA in the hippocampus of SCZ patients, compared to non-psychiatric control subjects, while the ADAM10 transcript was unaffected. Conversely, no differences in CAP2, SAP97, and ADAM10 protein levels were detected between SCZ and control individuals in both brain regions. To assess whether DLG1 and CAP2 transcript alterations were selective for SCZ, we also measured their expression in the superior frontal gyrus of patients affected by neurodegenerative disorders, like Parkinson’s and Alzheimer’s disease. Interestingly, also in Parkinson’s disease patients, we found a selective reduction of CAP2 mRNA levels relative to controls but unaltered protein levels. Taken together, we reported for the first time altered CAP2 expression in the brain of patients with psychiatric and neurological disorders, thus suggesting that aberrant expression of this gene may contribute to synaptic dysfunction in these neuropathologies. |
format | Online Article Text |
id | pubmed-8835961 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88359612022-02-12 Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post-Mortem Brain of Schizophrenia, Parkinson’s and Alzheimer’s Disease Patients Di Maio, Anna De Rosa, Arianna Pelucchi, Silvia Garofalo, Martina Marciano, Benedetta Nuzzo, Tommaso Gardoni, Fabrizio Isidori, Andrea M. Di Luca, Monica Errico, Francesco De Bartolomeis, Andrea Marcello, Elena Usiello, Alessandro Int J Mol Sci Article Schizophrenia (SCZ) is a mental illness characterized by aberrant synaptic plasticity and connectivity. A large bulk of evidence suggests genetic and functional links between postsynaptic abnormalities and SCZ. Here, we performed quantitative PCR and Western blotting analysis in the dorsolateral prefrontal cortex (DLPFC) and hippocampus of SCZ patients to investigate the mRNA and protein expression of three key spine shapers: the actin-binding protein cyclase-associated protein 2 (CAP2), the sheddase a disintegrin and metalloproteinase 10 (ADAM10), and the synapse-associated protein 97 (SAP97). Our analysis of the SCZ post-mortem brain indicated increased DLG1 mRNA in DLPFC and decreased CAP2 mRNA in the hippocampus of SCZ patients, compared to non-psychiatric control subjects, while the ADAM10 transcript was unaffected. Conversely, no differences in CAP2, SAP97, and ADAM10 protein levels were detected between SCZ and control individuals in both brain regions. To assess whether DLG1 and CAP2 transcript alterations were selective for SCZ, we also measured their expression in the superior frontal gyrus of patients affected by neurodegenerative disorders, like Parkinson’s and Alzheimer’s disease. Interestingly, also in Parkinson’s disease patients, we found a selective reduction of CAP2 mRNA levels relative to controls but unaltered protein levels. Taken together, we reported for the first time altered CAP2 expression in the brain of patients with psychiatric and neurological disorders, thus suggesting that aberrant expression of this gene may contribute to synaptic dysfunction in these neuropathologies. MDPI 2022-01-28 /pmc/articles/PMC8835961/ /pubmed/35163460 http://dx.doi.org/10.3390/ijms23031539 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Di Maio, Anna De Rosa, Arianna Pelucchi, Silvia Garofalo, Martina Marciano, Benedetta Nuzzo, Tommaso Gardoni, Fabrizio Isidori, Andrea M. Di Luca, Monica Errico, Francesco De Bartolomeis, Andrea Marcello, Elena Usiello, Alessandro Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post-Mortem Brain of Schizophrenia, Parkinson’s and Alzheimer’s Disease Patients |
title | Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post-Mortem Brain of Schizophrenia, Parkinson’s and Alzheimer’s Disease Patients |
title_full | Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post-Mortem Brain of Schizophrenia, Parkinson’s and Alzheimer’s Disease Patients |
title_fullStr | Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post-Mortem Brain of Schizophrenia, Parkinson’s and Alzheimer’s Disease Patients |
title_full_unstemmed | Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post-Mortem Brain of Schizophrenia, Parkinson’s and Alzheimer’s Disease Patients |
title_short | Analysis of mRNA and Protein Levels of CAP2, DLG1 and ADAM10 Genes in Post-Mortem Brain of Schizophrenia, Parkinson’s and Alzheimer’s Disease Patients |
title_sort | analysis of mrna and protein levels of cap2, dlg1 and adam10 genes in post-mortem brain of schizophrenia, parkinson’s and alzheimer’s disease patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835961/ https://www.ncbi.nlm.nih.gov/pubmed/35163460 http://dx.doi.org/10.3390/ijms23031539 |
work_keys_str_mv | AT dimaioanna analysisofmrnaandproteinlevelsofcap2dlg1andadam10genesinpostmortembrainofschizophreniaparkinsonsandalzheimersdiseasepatients AT derosaarianna analysisofmrnaandproteinlevelsofcap2dlg1andadam10genesinpostmortembrainofschizophreniaparkinsonsandalzheimersdiseasepatients AT pelucchisilvia analysisofmrnaandproteinlevelsofcap2dlg1andadam10genesinpostmortembrainofschizophreniaparkinsonsandalzheimersdiseasepatients AT garofalomartina analysisofmrnaandproteinlevelsofcap2dlg1andadam10genesinpostmortembrainofschizophreniaparkinsonsandalzheimersdiseasepatients AT marcianobenedetta analysisofmrnaandproteinlevelsofcap2dlg1andadam10genesinpostmortembrainofschizophreniaparkinsonsandalzheimersdiseasepatients AT nuzzotommaso analysisofmrnaandproteinlevelsofcap2dlg1andadam10genesinpostmortembrainofschizophreniaparkinsonsandalzheimersdiseasepatients AT gardonifabrizio analysisofmrnaandproteinlevelsofcap2dlg1andadam10genesinpostmortembrainofschizophreniaparkinsonsandalzheimersdiseasepatients AT isidoriandream analysisofmrnaandproteinlevelsofcap2dlg1andadam10genesinpostmortembrainofschizophreniaparkinsonsandalzheimersdiseasepatients AT dilucamonica analysisofmrnaandproteinlevelsofcap2dlg1andadam10genesinpostmortembrainofschizophreniaparkinsonsandalzheimersdiseasepatients AT erricofrancesco analysisofmrnaandproteinlevelsofcap2dlg1andadam10genesinpostmortembrainofschizophreniaparkinsonsandalzheimersdiseasepatients AT debartolomeisandrea analysisofmrnaandproteinlevelsofcap2dlg1andadam10genesinpostmortembrainofschizophreniaparkinsonsandalzheimersdiseasepatients AT marcelloelena analysisofmrnaandproteinlevelsofcap2dlg1andadam10genesinpostmortembrainofschizophreniaparkinsonsandalzheimersdiseasepatients AT usielloalessandro analysisofmrnaandproteinlevelsofcap2dlg1andadam10genesinpostmortembrainofschizophreniaparkinsonsandalzheimersdiseasepatients |